发明授权
- 专利标题： Antisense modulation of kinesin-like 1 expression
- 专利标题（中）： 驱动蛋白样1表达的反义调制
-
申请号： US11618167申请日： 2006-12-29
-
公开(公告)号： US07718628B2公开(公告)日： 2010-05-18
- 发明人: Kenneth W. Dobie , Erich Koller
- 申请人： Kenneth W. Dobie , Erich Koller
- 申请人地址： US CA Carlsbad
- 专利权人： Isis Pharmaceuticals, Inc.
- 当前专利权人： Isis Pharmaceuticals, Inc.
- 当前专利权人地址： US CA Carlsbad
- 代理机构： Knobbe Martens Olson & Bear LLP
- 主分类号： C07H21/02
- IPC分类号： C07H21/02 ; C07H21/04 ; A61K31/70 ; C12N5/00 ; C12Q1/68
摘要：
Antisense compounds, compositions and methods are provided for modulating the expression of kinesin-like 1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding kinesin-like 1. Methods of using these compounds for modulation of kinesin-like 1 expression and for treatment of diseases associated with expression of kinesin-like 1 are provided.
公开/授权文献
- US20080009456A1 ANTISENSE MODULATION OF KINESIN-LIKE 1 EXPRESSION 公开/授权日：2008-01-10
信息查询
